139 related articles for article (PubMed ID: 31876615)
1. Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.
Willame C; Gadroen K; Bramer W; Weibel D; Sturkenboom M
Pediatr Infect Dis J; 2020 Apr; 39(4):287-293. PubMed ID: 31876615
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis.
Jiang HY; Shi YD; Zhang X; Pan LY; Xie YR; Jiang CM; Deng M; Ruan B
Vaccine; 2019 May; 37(23):3031-3039. PubMed ID: 31036452
[TBL] [Abstract][Full Text] [Related]
3. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
[TBL] [Abstract][Full Text] [Related]
5. HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature.
Genovese C; LA Fauci V; Squeri A; Trimarchi G; Squeri R
J Prev Med Hyg; 2018 Sep; 59(3):E194-E199. PubMed ID: 30397675
[TBL] [Abstract][Full Text] [Related]
6. Safety of human papillomavirus vaccines: a review.
Stillo M; Carrillo Santisteve P; Lopalco PL
Expert Opin Drug Saf; 2015 May; 14(5):697-712. PubMed ID: 25689872
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.
Vichnin M; Bonanni P; Klein NP; Garland SM; Block SL; Kjaer SK; Sings HL; Perez G; Haupt RM; Saah AJ; Lievano F; Velicer C; Drury R; Kuter BJ
Pediatr Infect Dis J; 2015 Sep; 34(9):983-91. PubMed ID: 26107345
[TBL] [Abstract][Full Text] [Related]
9. Adverse events following HPV vaccination: 11 years of surveillance in Australia.
Phillips A; Hickie M; Totterdell J; Brotherton J; Dey A; Hill R; Snelling T; Macartney K
Vaccine; 2020 Aug; 38(38):6038-6046. PubMed ID: 32709432
[TBL] [Abstract][Full Text] [Related]
10. On the relationship between human papilloma virus vaccine and autoimmune diseases.
Pellegrino P; Carnovale C; Pozzi M; Antoniazzi S; Perrone V; Salvati D; Gentili M; Brusadelli T; Clementi E; Radice S
Autoimmun Rev; 2014 Jul; 13(7):736-41. PubMed ID: 24468416
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization in Ontario's female school-based HPV program.
Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
Rosillon D; Willame C; Tavares Da Silva F; Guignard A; Caterina S; Welby S; Struyf F
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1159-1167. PubMed ID: 32583515
[TBL] [Abstract][Full Text] [Related]
13. Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.
Liu Z; Zhang L; Yang Y; Meng R; Fang T; Dong Y; Li N; Xu G; Zhan S
J Med Internet Res; 2020 Jun; 22(6):e17446. PubMed ID: 32234696
[TBL] [Abstract][Full Text] [Related]
14. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M
J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232
[TBL] [Abstract][Full Text] [Related]
15. The comparative safety of human papillomavirus vaccines: A Bayesian network meta-analysis.
Huang R; Gan R; Zhang D; Xiao J
J Med Virol; 2022 Feb; 94(2):729-736. PubMed ID: 34453758
[TBL] [Abstract][Full Text] [Related]
16. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance.
Grimaldi-Bensouda L; Rossignol M; Koné-Paut I; Krivitzky A; Lebrun-Frenay C; Clet J; Brassat D; Papeix C; Nicolino M; Benhamou PY; Fain O; Costedoat-Chalumeau N; Courcoux MF; Viallard JF; Godeau B; Papo T; Vermersch P; Bourgault-Villada I; Breart G; Abenhaim L;
J Autoimmun; 2017 May; 79():84-90. PubMed ID: 28190705
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
[TBL] [Abstract][Full Text] [Related]
18. Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine.
Sy LS; Meyer KI; Klein NP; Chao C; Velicer C; Cheetham TC; Ackerson BK; Slezak JM; Takhar HS; Hansen J; Deosaransingh K; Liaw KL; Jacobsen SJ
Hum Vaccin Immunother; 2018 Feb; 14(2):412-419. PubMed ID: 29140750
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25 years: A systematic review and meta-analysis.
Li Y; Zhu P; Wu M; Zhang Y; Li L
Vaccine; 2020 Jan; 38(2):119-134. PubMed ID: 31831220
[TBL] [Abstract][Full Text] [Related]
20. Safety of HPV vaccines in the age of nonavalent vaccination.
Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL
Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
